{"news_desk": "National", "print_page": "20", "subsection_name": null, "section_name": "Health", "byline": {"original": "By GINA KOLATA", "person": [{"firstname": "Gina", "rank": 1, "lastname": "KOLATA", "organization": "", "role": "reported"}]}, "abstract": "Pfizer-funded study by Dr Steven Nissen of Cleveland Clinic published in New England Journal of Medicine indicates prescription-only, anti-inflammatory medication celecoxib is safer for patients with heart problems than naproxen or ibuprofen; decade-long research involved 24,000 patients with arthritis who had or were at high risk for heart disease; findings may increase prescriptions of celecoxib for long-term use because it does not appear to cause gastrointestinal bleeding.", "type_of_material": "News", "word_count": "1127", "keywords": [{"rank": "1", "value": "Celebrex (Drug)", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Pfizer Inc", "is_major": "Y", "name": "organizations"}, {"rank": "3", "value": "Clinical Trials", "is_major": "N", "name": "subject"}, {"rank": "4", "value": "Heart", "is_major": "Y", "name": "subject"}, {"rank": "5", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "name": "subject"}, {"rank": "6", "value": "Arthritis", "is_major": "Y", "name": "subject"}, {"rank": "7", "value": "Ibuprofen (Drug)", "is_major": "N", "name": "subject"}, {"rank": "8", "value": "New England Journal of Medicine", "is_major": "Y", "name": "organizations"}], "lead_paragraph": "A question has long hung over Celebrex: Did it cause heart attacks? Now, a clinical trial suggests it may be safer than drugs like ibuprofen and naproxen.", "pub_date": "2016-11-13T21:45:13Z", "document_type": "article", "source": "The New York Times", "snippet": "A question has long hung over Celebrex: Did it cause heart attacks? Now, a clinical trial suggests it may be safer than drugs like ibuprofen and naproxen....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/11/13/us/14heart/14heart-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/11/13/us/14heart/14heart-thumbWide.jpg"}, {"height": 540, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "540", "xlarge": "images/2016/11/13/us/14heart/14heart-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/11/13/us/14heart/14heart-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/11/13/us/14heart/14heart-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/11/13/us/14heart/14heart-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/11/14/health/celebrex-is-found-to-be-no-riskier-for-hearts-than-other-pain-drugs.html", "slideshow_credits": null, "blog": [], "_id": "5828def17c459f6a5fccdc04", "headline": {"main": "Celebrex Is Found to Be No Riskier for Hearts Than Other Pain Drugs", "print_headline": "Celebrex Is Found to Be No Riskier for Hearts Than Other Pain Drugs"}}